NG-Nitroarginine Methyl Ester: Clinical Trials

13 trials of NG-Nitroarginine Methyl Ester, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 recruiting, 2 active not recruiting. 4 Phase 2, 3 Not applicable, 3 Phase 1, 2 Early Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Recruiting 1
Not applicable3Completed 2, Recruiting 1
Phase 13Completed 3
Early Phase 12Active not recruiting 1, Recruiting 1
Phase 32Completed 2

Follow NG-Nitroarginine Methyl Ester: new trials by email Literature Review of NG-Nitroarginine Methyl Ester trials Research Report on NG-Nitroarginine Methyl Ester

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Heat, Microvascular Function and Aging
Passive Heating, L-NAME - Aging
Early Phase 1Active not recruitingWilliam Hughes202025-05-012026-07-09
Linking Affective Dynamics in Response to Daily Stress to Peripheral Vascular Function in Working Age Adults
NG-nitro-L-arginine methyl ester (L-NAME) - Major Depressive Disorder
Not applicableRecruitingUniversity of Delaware182025-01-062025-09-17
Effects of an Antioxidant Supplement on Blood Vessel Health
MitoQ, Placebo, MitoTempo - Healthy
Phase 2RecruitingUniversity of Georgia602024-07-012024-12-09
Sex Differences in the Vascular Effects of E-cigarette Use
Local heating + L-NAME (NG-nitro-L-arginine methyl ester; nitric oxide synthase inhibitor), Chronic estrogen exposure - E-cigarette Use
Early Phase 1RecruitingAnna Stanhewicz, PhD802023-12-022025-12-15
Estrogen and Microvascular Function
Nω-nitro-L-arginine methyl ester (L-NAME), Acetylcholine, Sodium Nitroprusside - Estrogen, Cardiovascular Diseases
Active not recruitingMedical College of Wisconsin452023-10-122026-07-29
Local Antioxidant Therapy Vasoconstriction Effects in Different Races
Control (Norepinephrine), Norepinephrine + Ascorbic Acid, Norepinephrine + L-NAME - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington222018-10-152024-06-11
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
BQ-788, BQ-123, L-Arginine - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington192018-10-012024-06-11
The Effect of Antioxidants on Skin Blood Flow-BH4
Control: Lacated Ringers, Apocynin, Allopurinol - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington162018-01-082018-09-26
Role of Epoxy-eicosatrienoic Acids in Post-occlusive Hyperemia and Thermal Hyperemia
Microdialysis of fluconazole, vehicle and N(G)-nitro-L-arginine-methyl ester (L-NMMA) - Healthy Volunteers
Not applicableCompletedUniversity Hospital, Grenoble202011-02-012012-09-05
Safety and Efficacy of L-NAME and Midodrine to Increase MAP
L-NAME, Midodrine, Placebo - Orthostatic Hypotension, Spinal Cord Injury
Phase 2CompletedUS Department of Veterans Affairs342010-05-012014-04-23
Exhaled Levels of Nitric Oxide
N-Nitro L-arginine-methylester (L-NAME) - Tetraplegia, Asthma
Phase 2 / Phase 3CompletedVA Office of Research and Development232006-12-012020-02-28
Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling
L-NAME, L-Arginine, Phenylephrine - Cardiovascular Diseases
Not applicableCompletedWashington University School of Medicine542005-09-012018-09-12
Prevention of Low Blood Pressure in Persons With Tetraplegia
N-Nitro L-arginine-methylester (L-NAME), Head-up Tilt maneuver - Hypotension, Spinal Cord Injury
Phase 2 / Phase 3CompletedUS Department of Veterans Affairs162003-06-012014-05-19

Conditions studied

Cardiovascular Diseases (6)  ·  Spinal Cord Injuries (3)  ·  Hypotension, Orthostatic (2)  ·  Quadriplegia (2)  ·  Asthma (1)  ·  Depressive Disorder, Major (1)  ·  Hypertension (1)  ·  Hypotension (1)  ·  Vaping (1)

Sponsors

The University of Texas at Arlington (3)  ·  US Department of Veterans Affairs (2)  ·  Anna Stanhewicz, PhD (1)  ·  Medical College of Wisconsin (1)  ·  University Hospital, Grenoble (1)  ·  University of Delaware (1)  ·  University of Georgia (1)  ·  VA Office of Research and Development (1)  ·  Washington University School of Medicine (1)  ·  William Hughes (1)

Countries

United States (12)  ·  France (1)

Top investigators

Jean-Luc Cracowski, MD,PhD (1)  ·  Jill Wecht, EdD (1)  ·  Miroslav Radulovic, MD (1)  ·  Robert Gropler, MD (1)  ·  William Bauman, MD (1)

Results publications

PMID 21762873, PMID 17385265, PMID 17965289, PMID 19651280, PMID 20012982, PMID 23700789

NIH funding

P20GM113125 (1), R01AG015466 (1)